These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs. Pleticha J; Heilmann LF; Evans CH; Asokan A; Samulski RJ; Beutler AS Mol Pain; 2014 Sep; 10():54. PubMed ID: 25183392 [TBL] [Abstract][Full Text] [Related]
6. Future potential and status of selective sodium channel blockers for the treatment of pain. Priest BT Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626 [TBL] [Abstract][Full Text] [Related]
8. Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses. Fattori V; Hohmann MS; Rossaneis AC; Pinho-Ribeiro FA; Verri WA Molecules; 2016 Jun; 21(7):. PubMed ID: 27367653 [TBL] [Abstract][Full Text] [Related]
9. The pathophysiology of pain. Garrett N; McShane F AANA J; 1999 Aug; 67(4):349-57. PubMed ID: 10497457 [TBL] [Abstract][Full Text] [Related]
10. What can chronic arthritis pain teach about developing new analgesic drugs? Witter J; Dionne RA Arthritis Res Ther; 2004; 6(6):279-81. PubMed ID: 15535840 [TBL] [Abstract][Full Text] [Related]
12. Elucidation of pathophysiology and treatment of neuropathic pain. Vranken JH Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930 [TBL] [Abstract][Full Text] [Related]
13. The pharmacogenetics of analgesia. Stamer UM; Stüber F Expert Opin Pharmacother; 2007 Oct; 8(14):2235-45. PubMed ID: 17927480 [TBL] [Abstract][Full Text] [Related]
14. The pharmacogenetics of analgesia: toward a genetically-based approach to pain management. Flores CM; Mogil JS Pharmacogenomics; 2001 Aug; 2(3):177-94. PubMed ID: 11535108 [TBL] [Abstract][Full Text] [Related]
15. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity. García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334 [TBL] [Abstract][Full Text] [Related]
16. Na Yang Y; Mis MA; Estacion M; Dib-Hajj SD; Waxman SG Trends Pharmacol Sci; 2018 Mar; 39(3):258-275. PubMed ID: 29370938 [TBL] [Abstract][Full Text] [Related]
17. Transient receptor potential channels - emerging novel drug targets for the treatment of pain. Sałat K; Moniczewski A; Librowski T Curr Med Chem; 2013; 20(11):1409-36. PubMed ID: 23409716 [TBL] [Abstract][Full Text] [Related]
18. [New aspects in pain research at Bayer]. Nopper R; Gebert I Fortschr Neurol Psychiatr; 2003 Dec; 71(12):683-9. PubMed ID: 14661162 [TBL] [Abstract][Full Text] [Related]
19. Lost but making progress--Where will new analgesic drugs come from? Borsook D; Hargreaves R; Bountra C; Porreca F Sci Transl Med; 2014 Aug; 6(249):249sr3. PubMed ID: 25122640 [TBL] [Abstract][Full Text] [Related]
20. No gain, no pain: NaV1.7 as an analgesic target. King GF; Vetter I ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]